Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials—data from the prospective German Tumour Registry Lymphatic Neoplasms...

por Knauf, Wolfgang, Aldaoud, Ali, Hutzschenreuter, Ulrich, Klausmann, Martine, Dille, Stephanie, Wetzel, Natalie, Jänicke, Martina, Marschner, Norbert
Publicado 2018

Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project

por Hurtz, Hans-Jürgen, Tesch, Hans, Göhler, Thomas, Hutzschenreuter, Ulrich, Harde, Johanna, Kruggel, Lisa, Jänicke, Martina, Marschner, Norbert
Publicado 2017

Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastat...

por Marschner, Norbert, Arnold, Dirk, Engel, Erik, Hutzschenreuter, Ulrich, Rauh, Jacqueline, Freier, Werner, Hartmann, Holger, Frank, Melanie, Jänicke, Martina
Publicado 2015

Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients

por Metz, Michael, Semsek, Dieter, Rogmans, Gunther, Hutzschenreuter, Ulrich, Fietz, Thomas, Harde, Johanna, Zacharias, Stefan, Hielscher, Carsten, Lorenz, Andreas, Zahn, Mark-Oliver, Guth, Dagmar, Liebers, Steffen, Berghorn, Michael, Grebhardt, Sina, Matillon, Christiane D., Egerer, Gerlinde, Potthoff, Karin
Publicado 2021